検索対象:     
報告書番号:
※ 半角英数字
 年 ~ 
 年

Synthesis and stability of $$^{76}$$Br-${it m}$-bromobenzylgianidine ($$^{76}$$Br-MBBG)

$$^{76}$$Br-${it m}$-ブロモベンジルグアニジン($$^{76}$$Br-MBBG)の合成と安定性

渡邉 茂樹; 花岡 宏史*; Liang, J. X.; 飯田 靖彦*; 遠藤 啓吾*; 石岡 典子

Watanabe, Shigeki; Hanaoka, Hirofumi*; Liang, J. X.; Iida, Yasuhiko*; Endo, Keigo*; Ishioka, Noriko

$$^{76}$$Br (t$$_{1/2}$$ = 16.2 h, $$beta$$$$^{+}$$ = 57%, EC = 43%) has intermediated half-life and may have great potentials as radionuclide for positron emission tomography (PET). We have produced $$^{76}$$Br via the $$^{76}$$Se(p,n)$$^{76}$$Br reaction using Cu$$_{2}$$$$^{76}$$Se target, and also have interest in bromine labeled radiopharmaceuticals. Radioiodine labeled ${it m}$-iodobenzylguanidine (MIBG) such as [$$^{123}$$I] or [$$^{131}$$I]-MIBG have been widely employed for imaging of myocardial function and neuroendcrine tumor with single photon emission computed tomography (SPECT). PET is superior in quantitative measurement to SPECT, thus positron emitter $$^{76}$$Br-labeled MIBG can be expected to employ as a novel imaging reagent for PET. In this study, we synthesized $$^{76}$$Br labeled meta-bromobenzylguanidine ($$^{76}$$Br-MBBG) for tumor imaging by PET to evaluated stability in serum and biodistribution of $$^{76}$$Br-MBBG using normal mice.

Access

:

- Accesses

InCites™

:

Altmetrics

:

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.